Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease

NCT02617017 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Parkinson

Interventions

DRUG: Buspirone
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris